Diseases, Conditions, Syndromes

WHO sees hope despite looming 750,000 virus death toll

The World Health Organization insisted Monday there was still hope of conquering the coronavirus pandemic despite the suffering behind the looming landmarks of 750,000 deaths and 20 million cases.

Vaccination

WHO urges Russia to follow guidelines on virus vaccine

The World Health Organization on Tuesday urged Russia to follow the established guidelines for producing safe and effective vaccines after Moscow announced plans to start swiftly producing COVID-19 jabs.

Diseases, Conditions, Syndromes

Chinese coronavirus vaccine approved for military use

China's military has approved a coronavirus vaccine for use within its ranks that has been developed by its research unit and a biotech firm, the company said Monday.

Medical research

Skin diseases study uses crowdsourcing to gather data

In 1906, English statistician Francis Galton happened to visit a livestock fair where fairgoers were invited to guess the dressed weight of an ox scheduled for imminent slaughter. Some 800 attendees took part and afterwards ...

Medications

FDA approves first drug for rare form of rickets

(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).

Cardiology

AHA: noninvasive testing ups LOS in patients with chest pain

(HealthDay)—Noninvasive cardiac testing leads to longer length of stay (LOS) for patients presenting to the emergency department with chest pain, according to a study published online Nov. 14 in JAMA Internal Medicine to ...

Diseases, Conditions, Syndromes

Doctors should evaluate hand function in RA, systemic sclerosis

(HealthDay)—Assessment of hand function is an important component in the clinical evaluation of patients with rheumatoid arthritis (RA) and systemic sclerosis (SSc), according to a study published online March 21 in the ...

Medications

FDA approves ocaliva for primary biliary cholangitis

(HealthDay)—Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response ...

page 1 from 5